IMMUNODEFICIENCY THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Overview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Therapy Type
     • Market Snippet, By Test Type
     • Market Snippet, By Disease Type
     • Market Snippet, By Distribution Chanel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • PEST Analysis
   • Industry Trends
   • Pipeline Analysis
   • Key Highlights
   • Epidemiology
   • Pricing List
   • Regulatory Scenario
   • Global Supply Chain Analysis

4. Global Immunodeficiency Therapeutics Market, By Therapy Type, 2017-2028 (US$ Million)

   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 - 2028
     • Segment Trends
   • Immunoglobulin Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Antibiotics Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Stem Cell and Gene Therapy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Immunodeficiency Therapeutics Market, By Test Type, 2017 - 2028 (US$ Million)

   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 - 2028
     • Segment Trends
   • Blood Test
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Prenatal Testing
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Immunodeficiency Therapeutics Market, By Disease Type, 2017 - 2028 (US$ Million)

   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 - 2028
     • Segment Trends
   • Antibody Deficiency
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Cellular Immunodeficiency
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Innate Immune Disorders
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Immunodeficiency Therapeutics Market, By Distribution Channel, 2017 - 2028 (US$ Million)

   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 - 2028
     • Segment Trends
   • Hospital Pharmacy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Retail Pharmacy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
   • Online Pharmacy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Immunodeficiency Therapeutics Market, By Region, 2017 - 2028 (US$ Million)

   • Introduction
     • Market Share Analysis, By Region, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
     • Regional Trends
   • North America
     • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
       • Germany
       • U.K.
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Market Size and Forecast, By Therapy Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Test Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Disease Type, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
     • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
       • South Africa
       • Central Africa
       • North Africa

9. Competitive Landscape

   • Company Profiles
     • Pfizer Inc.
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • CSL Behring
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Grifols, S.A.
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Abbott
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • ADMA Biologics, Inc.
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • AstraZeneca
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Baxter
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Bayer AG
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Biocon
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Bristol-Myers Squibb Company
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • BDI Pharma, Inc.
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Bharat Serums and Vaccines Ltd.
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Eli Lilly and Company
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • GlaxoSmithKline plc.
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Lupin Pharmaceuticals Inc.
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Novartis AG
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Octapharma AG
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Sanofi
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
     • Takeda Pharmaceutical Company Limited
       • Company Overview
       • Product Portfolio
       • Financial Performance
       • Recent Developments/Updates
       • Strategies
   • Analyst Views

10. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 26 figures on "Immunodeficiency Therapeutics Market” - Global Forecast to 2028.